BTN1A1, a element of the butyrophilin lineage, represents an fascinating therapeutic target for multiple immune disorders. The ICT-01-N297A antibody , specifically designed to bind BTN1A1, offers a novel https://www.targetmol.com/compound/ict_01_n297a